nitrendipine has been researched along with Hypotension in 4 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Hypotension: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The introduction of phosphodiesterase-5 inhibitors as sildenafil, tadalafil, or vardenafil, has tremendously improved the treatment of erectile dysfunction." | 9.13 | Sublingual application of liquid nitrendipine does not result in critical hypotension in healthy volunteers under phosphodiesterase-5 inhibition. ( Jung, F; Leithäuser, B; Park, JW, 2008) |
| "The introduction of phosphodiesterase-5 inhibitors as sildenafil, tadalafil, or vardenafil, has tremendously improved the treatment of erectile dysfunction." | 5.13 | Sublingual application of liquid nitrendipine does not result in critical hypotension in healthy volunteers under phosphodiesterase-5 inhibition. ( Jung, F; Leithäuser, B; Park, JW, 2008) |
| " In the present studies various doses of nitrendipine which is a new derivative of nifedipine were compared for their potencies to affect the blood pressure and heart rate, as well as the effect of drug-induced hypotension at the monoamine level in the spontaneously hypertensive rat (SHR) brain areas." | 3.67 | The relationship between calcium antagonist-induced hypotension and central monoaminergic system in spontaneously hypertensive rats. ( Hong, YL, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, JW | 1 |
| Leithäuser, B | 1 |
| Jung, F | 1 |
| Parry, MJ | 1 |
| Alabaster, VA | 1 |
| Cheeseman, HE | 1 |
| Cooper, K | 1 |
| deSouza, RN | 1 |
| Keir, RF | 1 |
| Yasky, J | 1 |
| Ferrario, CM | 1 |
| Hong, YL | 1 |
2 trials available for nitrendipine and Hypotension
| Article | Year |
|---|---|
Sublingual application of liquid nitrendipine does not result in critical hypotension in healthy volunteers under phosphodiesterase-5 inhibition.
Topics: Administration, Sublingual; Adult; Angina Pectoris; Blood Pressure; Carbolines; Cardiovascular Disea | 2008 |
Nocturnal hypotension and ACE inhibitors.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Circadian Rhythm; Enalapril; Female | 1993 |
2 other studies available for nitrendipine and Hypotension
| Article | Year |
|---|---|
Pharmacological profile of UK-74,505, a novel and selective PAF antagonist with potent and prolonged oral activity.
Topics: Administration, Oral; Animals; Aorta; Azepines; Blood Platelets; Brain; Calcium Channels, L-Type; Ca | 1994 |
The relationship between calcium antagonist-induced hypotension and central monoaminergic system in spontaneously hypertensive rats.
Topics: Adrenal Medulla; Animals; Blood Pressure; Brain; Chemical Phenomena; Chemistry; Dopamine; Femoral Ar | 1987 |